{"id":57514,"date":"2026-04-29T08:56:09","date_gmt":"2026-04-29T08:56:09","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/57514\/"},"modified":"2026-04-29T08:56:09","modified_gmt":"2026-04-29T08:56:09","slug":"switzerland-vvardis-reaches-unicorn-status-following-investment-from-apollo","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/57514\/","title":{"rendered":"Switzerland: vVardis reaches unicorn status following investment from Apollo"},"content":{"rendered":"<p><a href=\"https:\/\/www.linkedin.com\/company\/vvardis\/posts\/?feedView=all\" rel=\"nofollow noopener\" target=\"_blank\">vVardis Holding<\/a>, a Switzerland-based dental medtech company pioneering non-invasive cavity treatment, has achieved unicorn status following a strategic minority investment from US-based <a href=\"https:\/\/www.linkedin.com\/company\/apollo-global-management-inc\/\" rel=\"nofollow noopener\" target=\"_blank\">Apollo<\/a>-managed funds. The investment establishes vVardis as one of Europe\u2019s few privately owned, billion-dollar-plus, healthcare companies. vVardis\u2019 founders and co-CEOs, <a href=\"https:\/\/www.linkedin.com\/in\/dr-med-dent-haley-dr-med-dent-goly-abivardi-dmds-3562ab25b\/\" rel=\"nofollow noopener\" target=\"_blank\">Drs Haley and Goly Abivardi<\/a>, will retain a substantial majority shareholding in the company.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" width=\"480\" height=\"320\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/04\/Curodont.jpg\" alt=\"\" class=\"wp-image-102185\" style=\"width:334px;height:auto\"  \/>Curodont<\/p>\n<p>The investment will accelerate vVardis\u2019 next phase of global growth and commercial expansion of its Curodont technology platform \u2013 the first and only clinically proven, commercially available technology that treats early tooth decay throughout the depth of the lesion without drilling or needles.<\/p>\n<p>\u201cvVardis has built a differentiated business, with Drs Haley and Goly Abivardi pioneering a new category in dental care backed by peer-reviewed clinical studies,\u201d said Jeremy Honeth, partner and Andrea Vanni, managing director at Apollo. \u201cApollo Funds\u2019 investment supports the company\u2019s continued expansion in key markets across the US and Europe, bringing this restorative therapy to more practices and patients worldwide.\u201d<\/p>\n<p>Since the launch of Curodont\u00a0Repair Fluoride Plus in the US over two years ago, it has been used to treat approximately 3 million teeth, is now present in nearly 20% of general dental practices nationwide\u00a0and is one of the fastest-growing dental products in the country.<\/p>\n<p>The financial terms of the transaction were not disclosed.<\/p>\n","protected":false},"excerpt":{"rendered":"vVardis Holding, a Switzerland-based dental medtech company pioneering non-invasive cavity treatment, has achieved unicorn status following a strategic&hellip;\n","protected":false},"author":2,"featured_media":57515,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[4],"tags":[31998,20631,31999,32000,32001,17,32002],"class_list":["post-57514","post","type-post","status-publish","format-standard","has-post-thumbnail","category-switzerland","tag-andrea-vanni","tag-apollo","tag-goly-abivardi","tag-haley-abivardi","tag-jeremy-honeth","tag-switzerland","tag-vvardis"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116487165348318181","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/57514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=57514"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/57514\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/57515"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=57514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=57514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=57514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}